Works matching IS 18244785 AND DT 2021 AND VI 65 AND IP 4
Results: 14
Concomitant semi-quantitative and visual analysis improves the predictive value on treatment outcome of interim <sup>18</sup>F-fluorodeoxyglucose/positron-emission tomography in advanced Hodgkin lymphoma.
- Published in:
- Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 65, n. 4, p. 410, doi. 10.23736/S1824-4785.17.02993-4
- By:
- Publication type:
- Article
Prognostic value of interim FDG PET-CT in patients older than 60 years with diffuse large B-cell lymphoma treated by PMitCEBO plus rituximab comparison between deauville 5-point scale and international harmonization Project criteria.
- Published in:
- Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 65, n. 4, p. 402, doi. 10.23736/S1824-4785.16.02894-6
- By:
- Publication type:
- Article
Vesicular monoamine transporters expression in pheochromocytomas and paragangliomas according to scintigraphy and positron emission tomography behavior.
- Published in:
- Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 65, n. 4, p. 396, doi. 10.23736/S1824-4785.16.02887-9
- By:
- Publication type:
- Article
Evaluation and clinical quantification of neoplastic lesions and physiological structures in TOF- versus non-TOF-PET/MRI: a pilot study.
- Published in:
- Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 65, n. 4, p. 386, doi. 10.23736/S1824-4785.17.02790-X
- By:
- Publication type:
- Article
Role of <sup>18</sup>F-FDG-PET/CT in assessment of pediatric Hodgkin's lymphoma.
- Published in:
- Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 65, n. 4, p. 376, doi. 10.23736/S1824-4785.16.02695-9
- By:
- Publication type:
- Article
Challenges in theragnostics.
- Published in:
- Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 65, n. 4, p. 371, doi. 10.23736/S1824-4785.21.03417-8
- By:
- Publication type:
- Article
Theragnostics in primary and secondary liver tumors: the need for a personalized approach.
- Published in:
- Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 65, n. 4, p. 353, doi. 10.23736/S1824-4785.21.03407-5
- By:
- Publication type:
- Article
Theragnostic in neuroendocrine tumors.
- Published in:
- Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 65, n. 4, p. 342, doi. 10.23736/S1824-4785.21.03426-9
- By:
- Publication type:
- Article
Theragnostics in prostate cancer.
- Published in:
- Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 65, n. 4, p. 333, doi. 10.23736/S1824-4785.21.03419-1
- By:
- Publication type:
- Article
Dosimetry of nuclear medicine therapies: current controversies and impact on treatment optimization.
- Published in:
- Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 65, n. 4, p. 327, doi. 10.23736/S1824-4785.21.03418-X
- By:
- Publication type:
- Article
Side effects of theragnostic agents currently employed in clinical practice.
- Published in:
- Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 65, n. 4, p. 315, doi. 10.23736/S1824-4785.21.03411-7
- By:
- Publication type:
- Article
Theragnostic radionuclides: a clinical perspective.
- Published in:
- Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 65, n. 4, p. 306, doi. 10.23736/S1824-4785.21.03424-5
- By:
- Publication type:
- Article
Theragnostics before we found its name.
- Published in:
- Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 65, n. 4, p. 299, doi. 10.23736/S1824-4785.21.03410-5
- By:
- Publication type:
- Article
Theragnostics applications and challenges.
- Published in:
- Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 65, n. 4, p. 297, doi. 10.23736/S1824-4785.21.03439-7
- By:
- Publication type:
- Article